Chapters

Transcript

Video

ESMO26: Antonio Giordano, MD, PhD, on FOURLIGHT

Antonio Gioradano, MD, presents efficacy and safety of atirmociclib + fulvestrant in HR+/HER2- advanced breast cancer after progressing on prior CDK4/6 inhibitor - data from phase 2 FOURLIGHT-1 study.

Related Presenters

ADVERTISEMENT

Related Videos